Preeta Tyagi

MAGRIT: The Largest-Ever Phase III Lung Cancer Trial Aims to Establish a Novel Tumor-Specific Approach to Therapy

Preeta Tyagi, Beloo Mirakhur · Clinical Lung Cancer · 2009 · 174 citations

Medicine, Immune Checkpoint Inhibitor, Novel Tumor-specific Approach +6

Vatalanib (PTK787/ZK 222584) in Combination with FOLFOX4 Versus FOLFOX4 Alone as First-Line Treatment for Colorectal Cancer: Preliminary Results from the CONFIRM-1 Trial

Preeta Tyagi, Edward Chu, Vinay Jain · Clinical Colorectal Cancer · 2005 · 37 citations

Oncology, Gastrointestinal Oncology, Medicine +8

Bevacizumab, when Added to Paclitaxel/Carboplatin, Prolongs Survival in Previously Untreated Patients with Advanced Non–Small-Cell Lung Cancer: Preliminary Results from the ECOG 4599 Trial

Preeta Tyagi, Chandra P. Belani · Clinical Lung Cancer · 2005 · 33 citations

Oncology, Prolongs Survival, Ecog 4599 +9

Commentary on a Phase III Trial of Bevacizumab plus XELOX or FOLFOX4 for First-Line Treatment of Metastatic Colorectal Cancer: The NO16966 Trial

Preeta Tyagi, Axel Grothey · Clinical Colorectal Cancer · 2006 · 31 citations

Oncology, No16966 Trial, Gastrointestinal Oncology +8

Bexarotene in Combination with Chemotherapy Fails to Prolong Survival in Patients with Advanced Non–Small- Cell Lung Cancer: Results from the SPIRIT I and II Trials

Preeta Tyagi, Chandra P. Belani, Vinay Jain · Clinical Lung Cancer · 2005 · 21 citations

Prolong Survival, Medicine, Cancer Management +6